트립타민 조성물 및 방법
트립타민 화합물의 약학적으로 허용가능한 염, 세로토닌 5-HT2 수용체와 연관된 질환의 치료에 있어서의 이러한 염 형태의 용도, 상기 염 형태를 함유하는 흡입 투여에 적합한 것과 같은 약학적 조성물, 상기 약학적으로 허용가능한 염 형태를 (예를 들어, 흡입을 통해) 전달하는 방법, 및 세로토닌 5-HT2 수용체와 연관된 질환 또는 장애, 예컨대 중추신경계(CNS) 장애 또는 정신과적 장애를 상기 염 형태로 치료하는 방법이 개시된다. There are disclosed pharmaceutically acceptable salts of...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | kor |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | HUANG JAMES HE NIVOROZHKIN ALEX SHUKOOR MOHAMMED I PATHARE PRADIP M AVERY KENNETH L |
| description | 트립타민 화합물의 약학적으로 허용가능한 염, 세로토닌 5-HT2 수용체와 연관된 질환의 치료에 있어서의 이러한 염 형태의 용도, 상기 염 형태를 함유하는 흡입 투여에 적합한 것과 같은 약학적 조성물, 상기 약학적으로 허용가능한 염 형태를 (예를 들어, 흡입을 통해) 전달하는 방법, 및 세로토닌 5-HT2 수용체와 연관된 질환 또는 장애, 예컨대 중추신경계(CNS) 장애 또는 정신과적 장애를 상기 염 형태로 치료하는 방법이 개시된다.
There are disclosed pharmaceutically acceptable salts of tryptamine compounds, the use of such salt forms in the treatment of diseases associated with a serotonin 5-HT2 receptor, pharmaceutical compositions such as those adapted for inhalation administration containing the salt forms, methods of delivering the pharmaceutically acceptable salt forms (e.g., via inhalation), and methods of treating diseases or disorders associated with a serotonin 5-HT2 receptor, such as central nervous system (CNS) disorders or psychological disorders, with the salt forms. (Formula (I)) |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_KR20240134951A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>KR20240134951A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_KR20240134951A3</originalsourceid><addsrcrecordid>eNrjZFB827Xj9bK9b5sbXq_fo_Bm4YY3LRtfr9mj8HpDPxCvfL1pKg8Da1piTnEqL5TmZlB2cw1x9tBNLciPTy0uSExOzUstifcOMjIwMjEwNDaxNDV0NCZOFQBSHzBW</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>트립타민 조성물 및 방법</title><source>esp@cenet</source><creator>HUANG JAMES HE ; NIVOROZHKIN ALEX ; SHUKOOR MOHAMMED I ; PATHARE PRADIP M ; AVERY KENNETH L</creator><creatorcontrib>HUANG JAMES HE ; NIVOROZHKIN ALEX ; SHUKOOR MOHAMMED I ; PATHARE PRADIP M ; AVERY KENNETH L</creatorcontrib><description>트립타민 화합물의 약학적으로 허용가능한 염, 세로토닌 5-HT2 수용체와 연관된 질환의 치료에 있어서의 이러한 염 형태의 용도, 상기 염 형태를 함유하는 흡입 투여에 적합한 것과 같은 약학적 조성물, 상기 약학적으로 허용가능한 염 형태를 (예를 들어, 흡입을 통해) 전달하는 방법, 및 세로토닌 5-HT2 수용체와 연관된 질환 또는 장애, 예컨대 중추신경계(CNS) 장애 또는 정신과적 장애를 상기 염 형태로 치료하는 방법이 개시된다.
There are disclosed pharmaceutically acceptable salts of tryptamine compounds, the use of such salt forms in the treatment of diseases associated with a serotonin 5-HT2 receptor, pharmaceutical compositions such as those adapted for inhalation administration containing the salt forms, methods of delivering the pharmaceutically acceptable salt forms (e.g., via inhalation), and methods of treating diseases or disorders associated with a serotonin 5-HT2 receptor, such as central nervous system (CNS) disorders or psychological disorders, with the salt forms. (Formula (I))</description><language>kor</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240910&DB=EPODOC&CC=KR&NR=20240134951A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240910&DB=EPODOC&CC=KR&NR=20240134951A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>HUANG JAMES HE</creatorcontrib><creatorcontrib>NIVOROZHKIN ALEX</creatorcontrib><creatorcontrib>SHUKOOR MOHAMMED I</creatorcontrib><creatorcontrib>PATHARE PRADIP M</creatorcontrib><creatorcontrib>AVERY KENNETH L</creatorcontrib><title>트립타민 조성물 및 방법</title><description>트립타민 화합물의 약학적으로 허용가능한 염, 세로토닌 5-HT2 수용체와 연관된 질환의 치료에 있어서의 이러한 염 형태의 용도, 상기 염 형태를 함유하는 흡입 투여에 적합한 것과 같은 약학적 조성물, 상기 약학적으로 허용가능한 염 형태를 (예를 들어, 흡입을 통해) 전달하는 방법, 및 세로토닌 5-HT2 수용체와 연관된 질환 또는 장애, 예컨대 중추신경계(CNS) 장애 또는 정신과적 장애를 상기 염 형태로 치료하는 방법이 개시된다.
There are disclosed pharmaceutically acceptable salts of tryptamine compounds, the use of such salt forms in the treatment of diseases associated with a serotonin 5-HT2 receptor, pharmaceutical compositions such as those adapted for inhalation administration containing the salt forms, methods of delivering the pharmaceutically acceptable salt forms (e.g., via inhalation), and methods of treating diseases or disorders associated with a serotonin 5-HT2 receptor, such as central nervous system (CNS) disorders or psychological disorders, with the salt forms. (Formula (I))</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFB827Xj9bK9b5sbXq_fo_Bm4YY3LRtfr9mj8HpDPxCvfL1pKg8Da1piTnEqL5TmZlB2cw1x9tBNLciPTy0uSExOzUstifcOMjIwMjEwNDaxNDV0NCZOFQBSHzBW</recordid><startdate>20240910</startdate><enddate>20240910</enddate><creator>HUANG JAMES HE</creator><creator>NIVOROZHKIN ALEX</creator><creator>SHUKOOR MOHAMMED I</creator><creator>PATHARE PRADIP M</creator><creator>AVERY KENNETH L</creator><scope>EVB</scope></search><sort><creationdate>20240910</creationdate><title>트립타민 조성물 및 방법</title><author>HUANG JAMES HE ; NIVOROZHKIN ALEX ; SHUKOOR MOHAMMED I ; PATHARE PRADIP M ; AVERY KENNETH L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_KR20240134951A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>kor</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>HUANG JAMES HE</creatorcontrib><creatorcontrib>NIVOROZHKIN ALEX</creatorcontrib><creatorcontrib>SHUKOOR MOHAMMED I</creatorcontrib><creatorcontrib>PATHARE PRADIP M</creatorcontrib><creatorcontrib>AVERY KENNETH L</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>HUANG JAMES HE</au><au>NIVOROZHKIN ALEX</au><au>SHUKOOR MOHAMMED I</au><au>PATHARE PRADIP M</au><au>AVERY KENNETH L</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>트립타민 조성물 및 방법</title><date>2024-09-10</date><risdate>2024</risdate><abstract>트립타민 화합물의 약학적으로 허용가능한 염, 세로토닌 5-HT2 수용체와 연관된 질환의 치료에 있어서의 이러한 염 형태의 용도, 상기 염 형태를 함유하는 흡입 투여에 적합한 것과 같은 약학적 조성물, 상기 약학적으로 허용가능한 염 형태를 (예를 들어, 흡입을 통해) 전달하는 방법, 및 세로토닌 5-HT2 수용체와 연관된 질환 또는 장애, 예컨대 중추신경계(CNS) 장애 또는 정신과적 장애를 상기 염 형태로 치료하는 방법이 개시된다.
There are disclosed pharmaceutically acceptable salts of tryptamine compounds, the use of such salt forms in the treatment of diseases associated with a serotonin 5-HT2 receptor, pharmaceutical compositions such as those adapted for inhalation administration containing the salt forms, methods of delivering the pharmaceutically acceptable salt forms (e.g., via inhalation), and methods of treating diseases or disorders associated with a serotonin 5-HT2 receptor, such as central nervous system (CNS) disorders or psychological disorders, with the salt forms. (Formula (I))</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | kor |
| recordid | cdi_epo_espacenet_KR20240134951A |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | 트립타민 조성물 및 방법 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T13%3A18%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=HUANG%20JAMES%20HE&rft.date=2024-09-10&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EKR20240134951A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |